Arylamine N-Acetyltransferase
"Arylamine N-Acetyltransferase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.
| Descriptor ID |
D001191
|
| MeSH Number(s) |
D08.811.913.050.134.138
|
| Concept/Terms |
Arylamine N-Acetyltransferase- Arylamine N-Acetyltransferase
- Arylamine N Acetyltransferase
- N-Acetyltransferase, Arylamine
- Arylamine Acetyltransferases
- Acetyltransferases, Arylamine
- Arylamine Acetylases
- Acetylases, Arylamine
- Acetyl-CoA Arylamine N-Acetyltransferase
- Acetyl CoA Arylamine N Acetyltransferase
- Arylamine N-Acetyltransferase, Acetyl-CoA
- N-Acetyltransferase, Acetyl-CoA Arylamine
- Arylamine Acetylase
- Acetylase, Arylamine
|
Below are MeSH descriptors whose meaning is more general than "Arylamine N-Acetyltransferase".
Below are MeSH descriptors whose meaning is more specific than "Arylamine N-Acetyltransferase".
This graph shows the total number of publications written about "Arylamine N-Acetyltransferase" by people in this website by year, and whether "Arylamine N-Acetyltransferase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2007 | 3 | 1 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arylamine N-Acetyltransferase" by people in Profiles.
-
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 2023 07; 84(1):127-137.
-
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number. Am J Hum Genet. 2016 10 06; 99(4):860-876.
-
Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPs. Pharmacogenet Genomics. 2012 Apr; 22(4):305-9.
-
Bayesian analysis on meta-analysis of case-control studies accounting for within-study correlation. Stat Methods Med Res. 2015 Dec; 24(6):836-55.
-
NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol. 2011 Jan; 91(1):61-5.
-
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84.
-
Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):2090-7.
-
Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis. 2008 Jun; 29(6):1184-91.
-
Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2379-86.
-
GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007; 31(3):233-6.